TSX:AII

Almonty shares up close to 7% this week
·····

Almonty shares up close to 7% this week

Almonty Industries’ Nasdaq shares closed Friday at $18.66, down 0.69% on the day but up nearly 7% for the week amid strong demand for non-Chinese tungsten supply. The U.S. market will remain closed Monday for Memorial Day, with trading set to resume Tuesday. Almonty reported Q1 revenue of $25.4 million, a 221% increase, but posted a net loss of $5.3 million. The stock remains in focus after EU stockpile plans and record tungsten prices.
May 23, 2026

Stock Market Today

  • Genomic Test Could Spare Millions of Breast Cancer Patients Chemotherapy, Landmark Study Finds
    May 29, 2026, 8:16 PM EDT. A landmark study reveals that millions of breast cancer patients could safely skip chemotherapy thanks to the Prosigna genomic test, which analyses tumor genes to assess recurrence risk. The international OPTIMA trial, involving 4,429 patients, showed a 93.7% five-year cancer-free survival rate for those who avoided chemotherapy, nearly matching the 94.9% rate for those treated with it. Karen Bonham, a trial participant, described her relief upon learning she would not need chemotherapy, attributing her cancer-free status nine years post-diagnosis to the test's guidance. Experts hail the findings as gamechanging, potentially transforming breast cancer treatment by reducing unnecessary chemotherapy and its side effects, while maintaining patient safety.